in brain regions devoid of endogenous epinephrine ( cerebellum , frontal cortex and hippocampus ) , chronic treatment with pnmt inhibitors produced 1 ) a variable increase in tyrosine hydroxylase activity ( cerebellum only ) and 2 ) a reduction in norepinephrine turnover ;
C0014563
epinephrine
C0028351
norepinephrine